Deck Bio
PrivateLast Round
Seed
Apr 9, 2026
Total Funding Raised
$3.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Deck Bio is a biotechnology company developing T cell engagers that recognize multiple cancer signals to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deck Bio Comparables
Compare Deck Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clasp Therapeutics | 87% | |
| Crossbow Therapeutics | 82% | |
| 3T Biosciences | 74% |
Deck Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 9, 2026 |
Deck Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightEdge | Seed |
| Mission BioCapital | Seed |
| Impact Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$3.1M round with Mission BioCapital and BrightEdge
Deck Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Deck Bio's valuation, stock price, and market status.
Is Deck Bio a public or private company?
Deck Bio is a private company.
What is the current stock price of Deck Bio?
Deck Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Deck Bio worth (valuation)?
Valuation information for Deck Bio is not publicly available.
Can I buy Deck Bio stock?
Deck Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Deck Bio's last funding round?
Deck Bio's most recent funding round was Seed on April 9, 2026.
Who are the main investors in Deck Bio?
Key investors in Deck Bio include BrightEdge, Mission BioCapital, Impact Ventures.
Will Deck Bio IPO soon?
No public IPO plans have been announced for Deck Bio.
How can I track Deck Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deck Bio's secondary market activity and sign up for updates.